Clinuvel Pharmaceuticals LimitedASX: CUV

Encouraging interim safety results in Phase II OTR study

Feb 10, 2016 at 8:19 PM EST · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST · 3 pages · English

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.